← All stories
Markets

Shareholder pressures Capricor; Lilly dives deeper into vaccines

1 source ·1 article ·3h ago

Kaos Capital wants a “governance reset” to alter the Duchenne cell therapy maker’s strategic course. Elsewhere, Bristol Myers furthered efforts to build an “AI-powered” discovery engine.

Covered by 1 outlet

All coverage · 1 article